Results 191 to 200 of about 65,035 (206)

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

New England Journal of Medicine, 2002
Michael W Fried, K Rajender Reddy, Dieter Häussinger   +2 more
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly  

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

Lancet, The, 2014
Eric Lawitz
exaly  

Ribavirin

Reactions Weekly, 2013
openaire   +2 more sources

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

Lancet, The, 2015
Christophe Hézode, Tarik Asselah, K Rajender Reddy   +2 more
exaly  

RIBAVIRIN SUPPRESSES REPLICATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS IN CULTURES OF HUMAN ADULT T LYMPHOCYTES

Lancet, The, 1984
exaly  

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

Lancet, The, 2015
Eric Lawitz, Edward Gane, Dominique Guyader   +2 more
exaly  

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

Lancet, The, 2013
Kris V Kowdley, Eric Lawitz, Nezam Afdhal   +2 more
exaly  

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

Lancet, The, 2001
exaly  

Ribavirin

Reactions Weekly, 2011
openaire   +1 more source